Related Experiment Video
Updated: May 1, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Dose requirements of remifentanil for intubation in nonparalyzed Chinese children
Hua-Cheng Liu1, Wei-Ke Tao, Rui-Feng Zeng
1Department of Anesthesiology, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Insights
This study determined the effective doses of remifentanil for tracheal intubation in nonparalyzed Chinese children. The effective dose 50 (ED50) and effective dose 95 (ED95) of remifentanil combined with propofol were found to be lower than previously reported.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Pharmacology
Background:
- Determining effective doses of anesthetic agents is crucial for pediatric procedural safety.
- Remifentanil and propofol are commonly used for induction of general anesthesia in children.
- Optimizing intubation conditions in nonparalyzed children requires precise dosing of anesthetic agents.
Purpose of the Study:
- To determine the median effective dose (ED50) and the 95% effective dose (ED95) of remifentanil for tracheal intubation.
- To evaluate the efficacy of remifentanil in combination with propofol for intubation in nonparalyzed Chinese children.
- To compare the determined remifentanil doses with previously reported values.
Main Methods:
- A cohort of 47 ASA Class I children (aged 4-11 years) received a fixed dose of propofol (2.5 mg·kg(-1)).
- Remifentanil was administered intravenously with dose titration based on intubation conditions.
- Hemodynamic parameters and pulse oximetry were monitored throughout the procedure.
Main Results:
- The ED50 of remifentanil for satisfactory intubation was 2.30 μg·kg(-1) (95% CI: 2.28-2.31).
- The ED95 of remifentanil for satisfactory intubation was 2.75 μg·kg(-1) (95% CI: 2.59-3.35).
- These effective doses were lower than those reported in previous studies.
Conclusions:
- The ED50 and ED95 of remifentanil for adequate intubation in nonparalyzed Chinese children are lower than previously documented.
- The combination of propofol and remifentanil provides effective intubating conditions in this pediatric population.
- These findings suggest potential ethnic or demographic differences in anesthetic requirements.
Background:
The objective of this study was to determine ED50 and ED95 of remifentanil for intubation combined with propofol in nonparalyzed Chinese children.
Methods:
Forty-seven American Society of Anesthesiologists Class I children aged 4-11 years weighing 14-33.5 kg underwent general anesthesia with 2.5 mg·kg(-1) of intravenous propofol followed by remifentanil in Wenzhou, China. The initial dose of remifentanil was 2.5 μg·kg(-1) injected over 60 s. Intubation was attempted 30 s after the completion of remifentanil injection. Level of difficulty to intubate was graded on a scoring system. If the initial intubation condition was deemed satisfactory, subsequent remifentanil doses were decreased by 0.25 μg·kg(-1). If the intubating condition was deemed unsatisfactory, subsequent remifentanil doses were increased by 0.25 μg·kg(-1). Mean arterial pressure, heart rate, and pulse oximetry were documented before and after induction, immediately after intubation, and 1 min after intubation.
Results:
The ED50 of remifentanil used to render a satisfactory intubating condition used in combination with 2.5 mg·kg(-1) of propofol in nonparalyzed Chinese children was 2.30 μg·kg(-1) (95% confidence interval: 2.28-2.31 μg·kg(-1)), and the ED95 is 2.75 μg·kg(-1) (95% confidence interval: 2.59-3.35 μg·kg(-1)). These doses were lower than previously reported.
Conclusion:
When used in combination with 2.5 mg·kg(-1) of intravenous propofol, ED50 and ED95 of remifentanil for adequate intubation in nonparalyzed children were lower than previously reported, at 2.30 and 2.75 μg·kg(-1), respectively.
Related Concept Videos
Drug Dosing: Infants and Children
Depolarizing Blockers: Pharmocokinetics
Inhalational Anesthetics: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses

